search

1-20 of 260

Save search

Sort by

Sort Order Select

2 3 4 5

Journal Article

OA01 Long-term cardiovascular safety of febuxostat compared with allopurinol or no urate-lowering treatment in people with gout: a cohort study in UK primary care using the Clinical Practice Research Datalink

PDF

Richard Partington and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.001, https://doi.org/10.1093/rheumatology/keaf142.001

Published: 28 April 2025

Journal Article

OA40 Longitudinal metabolomic shifts in RA: insights from 49 NMR spectra show changes at 7 years

PDF

Pratyasha Saha and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.040, https://doi.org/10.1093/rheumatology/keaf142.040

Published: 28 April 2025

Journal Article

OA39 Assessment of pain types in recently diagnosed patients with inflammatory arthritis

PDF

Zoe Rutter-Locher and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.039, https://doi.org/10.1093/rheumatology/keaf142.039

Published: 28 April 2025

Journal Article

OA12 An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years

PDF

Kevin L Winthrop and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.012, https://doi.org/10.1093/rheumatology/keaf142.012

Published: 28 April 2025

Journal Article

OA28 VEXAS, a service evaluation in Rheumatology at Sheffield: “Seek, and ye shall find”

PDF

Sana Sharrack and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.028, https://doi.org/10.1093/rheumatology/keaf142.028

Published: 28 April 2025

Journal Article

OA21 Writing rheumatology outpatient clinic letters directly to patients: preferences, perspectives and support to change practice

PDF

Rebecca Goulding and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.021, https://doi.org/10.1093/rheumatology/keaf142.021

Published: 28 April 2025

Journal Article

OA41 Interstitial lung disease awareness among patients with rheumatoid arthritis in the UK

PDF

Ailsa Bosworth and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.041, https://doi.org/10.1093/rheumatology/keaf142.041

Published: 28 April 2025

Journal Article

OA25 Efficacy and safety of nipocalimab, an anti-FcRn monoclonal antibody, in primary Sjogren’s disease: results from a Phase 2, multicenter, randomized, placebo-controlled, double-blind study (DAHLIAS)

PDF

Jacques-Eric Gottenberg and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.025, https://doi.org/10.1093/rheumatology/keaf142.025

Published: 28 April 2025

Journal Article

OA32 A national survey of rheumatology telephone advice line support: user perspectives

PDF

Sarah Ryan and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.032, https://doi.org/10.1093/rheumatology/keaf142.032

Published: 28 April 2025

Journal Article

OA31 Stepping forward: improving foot care in Secondary Care Rheumatology

PDF

Mehek Chaudhri and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.031, https://doi.org/10.1093/rheumatology/keaf142.031

Published: 28 April 2025

Journal Article

OA23 Process evaluation of the Workwell Trial: perspectives from therapists and line managers

PDF

Yeliz Prior and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.023, https://doi.org/10.1093/rheumatology/keaf142.023

Published: 28 April 2025

Journal Article

OA09 Progression of foot involvement in individuals at risk of rheumatoid arthritis: findings from a UK cohort study

PDF

Lara S Chapman and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.009, https://doi.org/10.1093/rheumatology/keaf142.009

Published: 28 April 2025

Journal Article

OA19 The prevalence of fibromyalgia in people with inflammatory arthritis: an observational study in the Clinical Practice Research Datalink Aurum

PDF

Kolawole Adeniran and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.019, https://doi.org/10.1093/rheumatology/keaf142.019

Published: 28 April 2025

Journal Article

OA05 Virtual reality to educate and empower primary care practitioners in chronic pain management: the INSIGHT Programme

PDF

Jordan Tsigarides and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.005, https://doi.org/10.1093/rheumatology/keaf142.005

Published: 28 April 2025

Journal Article

OA04 A randomised controlled Phase II trial of LEVI-04, a novel neurotrophin-3 inhibitor, in knee osteoarthritis demonstrates substantially improved pain and function without deleterious effects on joint structure

PDF

Philip G Conaghan and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.004, https://doi.org/10.1093/rheumatology/keaf142.004

Published: 28 April 2025

Journal Article

OA14 The effect of biologic disease-modifying antirheumatic drugs on the neutrophil-lymphocyte ratio in psoriatic arthritis patients

PDF

Martin Lauran and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.014, https://doi.org/10.1093/rheumatology/keaf142.014

Published: 28 April 2025

Journal Article

OA36 Embedding quality improvement across paediatric and adolescent rheumatology: the JIA Learn experience

PDF

Flora McErlane and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.036, https://doi.org/10.1093/rheumatology/keaf142.036

Published: 28 April 2025

Journal Article

OA27 Differential activation of lysophosphatidic acid regulated genes in diffuse and limited cutaneous systemic sclerosis

PDF

Medha Kanitkar and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.027, https://doi.org/10.1093/rheumatology/keaf142.027

Published: 28 April 2025

Journal Article

OA34 The contributions of Patient and Public Involvement and Engagement groups to the conduct of a scoping review of non-pharmacological interventions for reducing fatigue in children and young people with musculoskeletal conditions

PDF

Katie Fishpool and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.034, https://doi.org/10.1093/rheumatology/keaf142.034

Published: 28 April 2025

Journal Article

OA33 A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: the ADAPT feasibility trial

PDF

Melanie Sloan and others

Rheumatology, Volume 64, Issue Supplement_3, April 2025, keaf142.033, https://doi.org/10.1093/rheumatology/keaf142.033

Published: 28 April 2025

2 3 4 5

Modify your search

Availability

NARROW

Format

Type

Section

Publication date

OA01 Long-term cardiovascular safety of febuxostat compared with allopurinol or no urate-lowering treatment in people with gout: a cohort study in UK primary care using the Clinical Practice Research Datalink

OA40 Longitudinal metabolomic shifts in RA: insights from 49 NMR spectra show changes at 7 years

OA39 Assessment of pain types in recently diagnosed patients with inflammatory arthritis

OA12 An update on the integrated safety analysis of filgotinib in patients with moderate to severe active rheumatoid arthritis over a median of 4.3 years

OA28 VEXAS, a service evaluation in Rheumatology at Sheffield: “Seek, and ye shall find”

OA21 Writing rheumatology outpatient clinic letters directly to patients: preferences, perspectives and support to change practice

OA41 Interstitial lung disease awareness among patients with rheumatoid arthritis in the UK

OA25 Efficacy and safety of nipocalimab, an anti-FcRn monoclonal antibody, in primary Sjogren’s disease: results from a Phase 2, multicenter, randomized, placebo-controlled, double-blind study (DAHLIAS)

OA32 A national survey of rheumatology telephone advice line support: user perspectives

OA31 Stepping forward: improving foot care in Secondary Care Rheumatology

OA23 Process evaluation of the Workwell Trial: perspectives from therapists and line managers

OA09 Progression of foot involvement in individuals at risk of rheumatoid arthritis: findings from a UK cohort study

OA19 The prevalence of fibromyalgia in people with inflammatory arthritis: an observational study in the Clinical Practice Research Datalink Aurum

OA05 Virtual reality to educate and empower primary care practitioners in chronic pain management: the INSIGHT Programme

OA04 A randomised controlled Phase II trial of LEVI-04, a novel neurotrophin-3 inhibitor, in knee osteoarthritis demonstrates substantially improved pain and function without deleterious effects on joint structure

OA14 The effect of biologic disease-modifying antirheumatic drugs on the neutrophil-lymphocyte ratio in psoriatic arthritis patients

OA36 Embedding quality improvement across paediatric and adolescent rheumatology: the JIA Learn experience

OA27 Differential activation of lysophosphatidic acid regulated genes in diffuse and limited cutaneous systemic sclerosis

OA34 The contributions of Patient and Public Involvement and Engagement groups to the conduct of a scoping review of non-pharmacological interventions for reducing fatigue in children and young people with musculoskeletal conditions

OA33 A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: the ADAPT feasibility trial

Email alerts

Modify your search

Publication date

Email alerts

This Feature Is Available To Subscribers Only